Treme Bio
PrivateLast Round
Series B
Extension
Jan 27, 2026
Total Funding Raised
$219M
Company Overview
Treme Bio is a biotechnology company developing ProLymphNano, a patented drug delivery technology that focuses on the lymphatic system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
drug delivery platformlymphatic targetingnanoparticle drug deliverydrug delivery technologynanomedicinetargeted drug deliverybiotech licensingsustained releasedrug formulationpayload deliverybiodegradable nanoparticles
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Treme Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Treme Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 27, 2026 | ||||
| Series B | Nov 13, 2024 | ||||
| Series A Extension | Mar 8, 2022 | ||||
| Series A | Jun 22, 2021 |
Treme Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B Extension |
| Agent Capital | Series B |
| Balyasny Asset Management L.P. | Series B Extension |
| SV Health Investors | Series B Extension, Series A, Series A Extension, Series B |
| Alexandria Venture Investments | Series B Extension, Series A, Series A Extension, Series B |
| Delos Capital Partners | Series B Extension, Series B |
| Polaris Partners | Series B Extension, Series B, Series A Extension |
Treme Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Treme Bio's valuation, stock price, and market status.
Firmographic Details
HeadquartersAtlanta, Georgia
Year Founded2026
Last FundingJan 27, 2026